Delivery Order SPE2DB22D2206-SPE2DB25FHM52
Award Date 6/17/25
Potential Completion Date 7/10/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials, with a firm fixed price ceiling value of $10,691.34 and an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for ONIVYDE 43 mg/10 ml vials, valued at $10,691.34 under a firm fixed price contract type. The award was made on September 23, 2025, with an ultimate completion date of October 15, 2025, and the work will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order draws from AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 mL vials on September 4, 2025, with an ultimate completion date of September 25, 2025. This firm fixed price delivery order represents a non-competitive procurement awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the company's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $3,563.78 delivery order from the Defense Logistics Agency (DLA) on April 22, 2025, for ONIVYDE 43 mg/10 mL vials. This firm fixed-price contract, with an ultimate completion date of May 13, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,127.56 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 mL vials. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,691.34 delivery order to AmerisourceBergen Drug Corp for ONIVYDE 43 mg/10 mL vials on June 5, 2025, with completion targeted for June 27, 2025. ONIVYDE (irinotecan liposome injection) is a chemotherapy agent used in cancer treatment, reflecting the breadth of pharmaceutical products supplied through federal medical procurement channels. This non-competitive delivery order is priced on a firm fixed-price basis and will be performed at the vendor's...
- This federal contract award is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on April 1, 2025, with a ceiling value of $7,127.56 and a completion date of April 22, 2025. The contract is a Delivery Order under a Firm Fixed Price contract type. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,404.40 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive award under an existing indefinite delivery contract vehicle. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,454.56 by the Defense Logistics Agency's Medical Supply Chain on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The company, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $10,976.50 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX). The order is to be fulfilled at AmerisourceBergen's corporate office...